John R. Lynn, M.D. Lectureship in Ophthalmology (RP1604D)

Dallas, TX US
April 9, 2016

Describe current treatment strategies for glaucoma with an emphasis upon comprehensive evaluation and medical treatment as well as minimally invasive surgical techniques.

Target Audience

The course is designed for practicing and academic ophthalmologists, residents and fellows in training, and other health care providers interested in a comprehensive update on the advances in medical and surgical treatment of glaucoma.

 

Learning Objectives

At the conclusion of this course, participants should be able to link the education objectives to Core Competencies (Medical Knowledge and Patient Care) and be able to:

  • Assess advantages and disadvantages of MIGS when selecting surgical therapy
  • Evaluate and employ new glaucoma treatment options
  • Reassess patient care using individualized glaucoma treatment regimens
  • Evaluate and utilize developing pharmaceutical agents for the treatment of glaucoma
  • Incorporate new techniques to manage complications of glaucoma filtration surgery
Course summary
Available credit: 
  • 3.50 AMA
  • 3.50 Attendance
Course opens: 
04/09/2016
Course expires: 
04/09/2017
Event starts: 
04/09/2016 - 8:30am CDT
Event ends: 
04/09/2016 - 12:30pm CDT
Cost:
$0.00
T. Boone Pickens Biomedical Building Auditorium
6001 Forest Park
UT Southwestern Medical Center
Dallas, TX 75235
United States

COURSE DIRECTORS
Jess T. Whitson, M.D., FACS
Professor of Ophthalmology
UT Southwestern Medical Center, Dallas, TX

James P. McCulley, M.D., FACS, FRCOphth(UK)
Professor and Chair of Ophthalmology
The David Bruton, Jr. Chair in Ophthalmology
UT Southwestern Medical Center, Dallas, TX

 

Accreditation and Designation Statements

The University of Texas Southwestern Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Available Credit

  • 3.50 AMA
  • 3.50 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.